APOLLOMICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 USD | -3.19% |
|
-2.44% | -58.55% |
| May. 08 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
| May. 08 | Apollomics, Inc. announced that it has received $5.75 million in funding | CI |
Chart calendar Apollomics, Inc.
2969fe1416fb576761119b8921.uckb3bzFOlldQOsE0-18OX7cpkWtesIFdfHuQRTT5Ss._oJV6OXzdSg5FZtyl7IVSi3x5wz7Q-9rQ8OYNkG0lBuPhVno1INoIRgwug~804f3ce70d220c2fcfa38ac5bfe54ff8
Upcoming events on Apollomics, Inc.
Past events on Apollomics, Inc.
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting |
| 2024-03-28 08:30 am | Q4 2023 Earnings Call |
| 2024-03-28 07:00 am | Q4 2023 Earnings Release |
| 2024-02-14 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-18 11:00 am | B. Riley Securities Oncology Conference - Track 2 |
| 2024-01-08 01:30 pm | Biotech Showcase |
| 2023-12-06 11:30 am | H.C. Wainwright Precision Oncology Virtual Conference |
| 2023-12-02 06:40 pm | IASLC North America Lung Cancer Conference - Abstract No: PP01.104 |
| 2023-10-23 06:00 am | European Society for Medical Oncology Congress - Abstract Number: #1379P |
| 2023-10-21 04:15 am | European Society for Medical Oncology Congress - Presentation Number: 502MO |
| 2023-10-02 08:30 am | Q2 2023 Earnings Call |
| 2023-09-28 04:17 pm | Q2 2023 Earnings Release |
| 2023-09-13 10:30 am | H.C. Wainwright Global Investment Conference |
| 2023-04-14 02:00 pm | R. Bryan Miller Symposium |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 4,30 - | 3,23 0,85 279.88% | 0,50 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -44,6 -44,4 -0.52% | -55,4 -41,0 -35.02% | -42,1 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -45,4 -49,2 7.72% | -56,0 -54,7 -2.33% | -60,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -241 -52,8 -356.08% | -173 -118 -45.88% | -63,0 |
|
Net income Million USD | Released Forecast Spread | -94,8 | -241 -52,8 -356.08% | -173 -118 -45.89% | -63,0 |
|
EPS USD | Released Forecast Spread | -0,23 | -0,62 -0,59 -5.08% | -2,32 -1,37 -69.34% | -0,64 |
| Announcement Date | 29/09/22 | 28/04/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 | -15,3 | -15,5 | -16,1 | -16,6 | -17,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 | -15,3 | -15,5 | -16,1 | -16,6 | -17,1 |
|
Net income Million USD | Released Forecast Spread | -14,7 | -15,3 | -15,5 | -16,1 | -16,6 | -17,1 |
|
EPS USD | Released Forecast Spread | -0,16 | -0,15 | -0,17 | -0,18 | -0,16 | -0,14 |
| Announcement Date | - | - | - | - | - | - |
More events
Past sector events for Apollomics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APLM Stock
- Calendar Apollomics, Inc.